NCT02636218View on ClinicalTrials.gov

Ketamine Infusion in Neurologic Deficit

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 26, 2016

Primary Completion Date

March 31, 2021

Study Completion Date

November 15, 2023

Conditions
Subarachnoid Hemorrhage
Interventions
DRUG

Ketamine

500 ml of ketamine (0.2 mg/ml) infused at 5 ug/kg/min for 4 hours.

DRUG

0.9% NaCl

500 ml of 0.9% NaCl infused at 5 ug/kg/min for 4 hours.

Trial Locations (1)

M5B 1W8

St Michael's Hospital, Toronto

Sponsors
All Listed Sponsors
collaborator

Defence Research and Development Canada

INDUSTRY

lead

Unity Health Toronto

OTHER